Find Academic Supervisors

Jian ZhangView profile

Assistant Professor

• Biomedical Engineering
• Mechanobiology
• Cancer Metabolism
• +5 more

Jian Zhang is an Assistant Professor in the Department of Biomedical Engineering at the University of Arkansas. He obtained his B.S. in Theoretical and Applied Mechanics from Peking University (2011) and a Ph.D. in Biomedical Engineering from Carnegie Mellon University (2016), followed by postdoctoral research at Vanderbilt University (2017-2022). His work integrates engineering , mechanics , and computational biology to study cancer mechanobiology and regenerative medicine. Education: B.S., Theoretical & Applied Mechanics, Peking University (2011) Ph.D., Biomedical Engineering, Carnegie Mellon University (2016) Dr. Zhang's research focuses on cancer mechano-metabolism —how mechanical forces interact with cellular bioenergetics to influence tumor progression. His lab develops bioengineering tools and computational models to study cell migration in 3D environments, nuclear mechanics, and extracellular matrix interactions. Recent work explores leader-follower dynamics in collective invasion and mitochondrial transfer in aggressive cancers. The 15 most recent publications highlight themes in cancer metabolism , nuclear deformation , and matrix stiffness , with applications in metastasis and regenerative medicine. His articles span computational modeling of energy-driven invasion hierarchies, biophysical studies of nuclear mechanics, and translational research connecting tissue density to cancer progression. At the University of Arkansas, Dr. Zhang teaches BMEG 26104 Introduction to Biomedical Engineering (Fall) and BMEG 4700V/5700V Special Topics: Physics of the Cell (Spring). The Zhang Lab (Cell Biophysics Laboratory) emphasizes collaborative research, mentorship, and the development of precision mechanomedicine tools to address challenges in cancer and regenerative medicine.

• Magnetic resonance spectroscopic imaging
• Tumor micro-environment imaging
• Multinuclear MRI (¹H/²³Na)
• +4 more

Sandeep Kumar Mishra, PhD, is an Associate Research Scientist in the Department of Radiology & Biomedical Imaging at Yale School of Medicine, where he holds a primary appointment in the Magnetic Resonance Research Center within the Division of Bioimaging Sciences. He completed his doctoral training at Pondicherry University (2017) and finished post-doctoral research at Yale in 2024 before transitioning to his current research-intensive faculty role. Education: PhD, Pondicherry University – 2017 Post-doctoral Associate, Yale University – 2024 Research Focus: Mishra’s work integrates multinuclear magnetic resonance spectroscopy, responsive paramagnetic probes, and nano-constructs to quantify the tumor microenvironment. Major themes include in-vivo mapping of interstitial pH and sodium gradients in gliomas, development of Fe(II)/Co(II)/Ni(II)-DOTA tetraglycinate complexes for simultaneous pH–temperature sensing, and engineering dual-modal nano-agents that couple MR angiography with therapeutic delivery (chemo-photothermal, cryo-ablation, MMP inhibition). Publication Trends: Across 28 peer-reviewed articles (2016-2025) he demonstrates a sustained trajectory in cancer imaging, moving from theranostic nanoparticles toward sophisticated spectroscopic imaging of tumor acid–base and ionic homeostasis, with increasing translational orientation involving rodent glioma and hepatocellular carcinoma models. Collaborations & Affiliations: He is embedded in Yale’s inter-disciplinary MR research ecosystem, collaborating recurrently with faculty in Radiology, Biomedical Engineering, and the Magnetic Resonance Research Center (D. Coman, F. Hyder, P. Herman, J. Verhagen, J. Santana, A. Shewarega). Contact: sandeepkmishra11@gmail.com | Magnetic Resonance Research Center, 300 Cedar Street, New Haven, CT 06519, USA

Johanne ThunesView profile

Research Fellow

• Digitalization in the Public Sector
• IT Strategy
• IT Outsourcing and Insourcing
• +2 more

Johanne Thunes is a Research Fellow at the Department of Informatics (IFI), University of Oslo, specializing in Information Systems. She holds a Master’s degree in Informatics and a Bachelor’s degree in both Informatics and Political Science from UiO. Her research focuses on digitalization in the public sector, IT strategy, low-code development, and IT outsourcing/insourcing dynamics. She has contributed to prominent conferences like HICSS and ECIS, addressing topics such as digital government transformation and low-code-driven backsourcing. Thunes teaches courses on platform ecosystems, software engineering, and systems design. She is affiliated with the Information Systems research group and serves on the Department Board at IFI. Education: Master’s in Informatics: Design, Use & Interaction, UiO (2020–2022) Bachelor’s in Informatics: Design, Use & Interaction, UiO (2018–2020) Bachelor’s in Political Science, UiO (2015–2018) Teaching Highlights: IN5320 – Development in Platform Ecosystems (2022) IN1050 – Introduction to Design, Use, Interaction (2019–2021) IN2000 – Software Engineering with Project Work (2021–2022) Research Trends: Her work bridges IT strategy and public sector challenges, emphasizing resilience, governance, and low-code solutions for organizational agility. Recent publications explore targeted insourcing models and backsourcing phenomena in digital transformation contexts.

Susan BrooksView profile

Professor

• Cancer Biology
• Glycobiology
• Cell Signaling
• +4 more

Professor Susan Brooks is a faculty member at Oxford Brookes University in the School of Biological and Medical Sciences . Her research focuses on glycobiology , cancer progression , and the role of extracellular vesicles in metastasis. Professor of Cell Biology Director of Researcher Development Focus on breast and ovarian cancer Specialized in glycosylation mechanisms Research Interests : Dr. Brooks' work explores how aberrant glycosylation of proteins and glycans influences cancer cell behavior, including metastasis and drug resistance . Her recent studies examine extracellular vesicles as diagnostic tools and therapeutic targets. Article Trends : Over 25 years, Dr. Brooks has published 15+ articles on glycosylation patterns in breast and ovarian cancer. Key areas include lectin binding , miRNA regulation , and radiation-induced metastatic changes . Her work bridges cell biology and clinical applications .

Justin EnglishView profile

Assistant Professor

• Directed Evolution
• Protein Engineering
• Molecular Tool Development
• +5 more

Justin English serves as Assistant Professor of Biochemistry at the University of Utah School of Medicine, where he develops molecular tools to investigate human health and disease mechanisms through directed evolution and protein engineering approaches. Education: B.A. from Cornell University Ph.D. from University of North Carolina at Chapel Hill Research Focus: Dr. English's laboratory specializes in Directed Evolution and Protein Engineering to create molecular tools for studying G-protein Coupled Receptors (GPCRs) , cell signaling pathways , and neuroscience applications . His work integrates synthetic biology with classical pharmacology to develop innovative platforms like VEGAS for mammalian cell evolution and TRUPATH for GPCR transducerome analysis, with significant implications for drug discovery and therapeutic development. Publication Trends: Analysis of his 2019-2025 publications reveals consistent focus on GPCR biology, featuring breakthroughs in biosensor development (nanobody-based receptor monitoring), chemogenetic tools (BioTAC system), and high-throughput screening platforms. His research demonstrates strong translational potential in neuroscience, particularly through engineered mouse models for psychedelic drug studies and molecular tools for mapping small-molecule interactomes. Research Environment: Dr. English leads an active laboratory within the University of Utah's Department of Biochemistry, leveraging institutional core facilities for biochemical and molecular studies. His research program maintains strong collaborative ties with neuroscience and pharmacology groups, with ongoing projects focused on advancing molecular engineering techniques for biomedical applications as detailed on his lab website.

Jennifer Sass-BrownView profile

Lecturer

• Speech-Language Pathology
• Pragmatics
• Child Language Disorders
• +3 more

Jennifer Sass-Brown serves as a Lecturer in the Department of Communication Arts, Sciences, and Disorders within Brooklyn College's School of Humanities and Social Sciences. She teaches core courses including Nature of Speech-Language Disorder, Intervention for Specific Language Disorders, and Diagnostics in Speech-Language Pathology while maintaining active clinical supervision roles and departmental committee leadership through 2021. Her academic credentials include: Bachelor of Arts in Speech-Language Pathology/Audiology from Brooklyn College (1994) Master of Science in Speech-Language Pathology from Brooklyn College (1997) Dr. Sass-Brown's research centers on pragmatics as the foundation of effective communication, emphasizing cultural diversity and mutual respect. She pioneers community-based interventions including therapy dog programs for autism communication development and the Pre-Literacy and Comprehension Program targeting emergent literacy skills in preschoolers through tailored language activities. Her professional recognition includes: Honored Faculty Member Award from BCNSSLHA (2017) As a dedicated mentor, she advises BCNSSLHA and the Graduate Student Organization while founding the 'Communicating with Our Community' program connecting students with 28+ local charities. She coordinates cross-disciplinary therapy teams at Tammy's Toddlers Daycare and mentors student-led initiatives including graduate peer mentoring and health/wellness seminars. Her community leadership extends to volunteer coordination with Heaven Can Wait Animal Rescue and multidisciplinary collaboration with occupational/physical therapists to develop integrated intervention strategies for young children.

• Quantum Information
• Quantum Control
• Precision Spectroscopy
• +3 more

Dr. Fabian Schmid is a Researcher affiliated with the Institute for Quantum Electronics at ETH Zürich, working within the Professorship for Experimental Quantum Information . His research focuses on quantum control, precision spectroscopy, and optical frequency comb technologies. Key applications include molecular ion manipulation, laser cooling techniques, and advanced spectroscopic methods for atomic and molecular systems. His work bridges quantum physics and optics, with contributions to ultra-stable laser systems, low-repetition-rate frequency combs, and high-resolution spectroscopic measurements. Recent efforts target applications in trapped ion systems and new boson constraints via calcium isotope studies. Schmid's experimental setups often involve precision engineering of optical components and cavity-stabilized laser systems. Notable experimental achievements include demonstrating quantum control over single molecular ions (H₂⁺) and developing number-resolved detection methods for Coulomb crystals. His research also explores synergies between dual-species laser cooling and cavity-based technologies. While currently holding no listed academic awards, Schmid's contributions are evident through his prolific publishing record in top-tier physics journals. His lab work integrates cutting-edge quantum optics with atomic physics to advance fundamental understanding and precision measurement capabilities.

Nikolaus RajewskyView profile

Professor

• RNA Biology
• Gene Regulation
• Single-Cell Transcriptomics
• +6 more

Nikolaus Rajewsky is a leading Professor at the Max Delbrück Center for Molecular Medicine (MDC) and Charité – Universitätsmedizin Berlin , where he founded and directs the Berlin Institute for Medical Systems Biology (BIMSB) . His lab integrates experimental (biochemistry, molecular biology) and computational (bioinformatics, physics) approaches to study RNA regulation in gene expression , with applications to developmental biology, regeneration, neurodegenerative diseases, and cancer . Using model systems like C. elegans , planaria, and human brain organoids, his team pioneers cutting-edge methods such as MirDeep , DistMap , and FLAM-seq for RNA analysis. His research focuses on single-cell transcriptomics , spatial RNA sequencing , and circular RNA (circRNA) regulation , revealing novel roles for circRNAs like CDR1as in neuropsychiatric disorders. Recent work includes 3D tumor microenvironment mapping and computational modeling of RNA metabolism in diseases. Scientific Awards : Gottfried Wilhelm Leibniz Prize (2012) EMBO Membership (2010) Honorary PhD, Sapienza University of Rome (2014) Berlin Science Award (2009) His team's recent articles highlight breakthroughs in 3D spatial transcriptomics , circRNA degradation mechanisms , and mitochondrial disease modeling using human brain organoids. The lab actively collaborates with clinical partners across Charité and European institutions, driving the LifeTime initiative for cell-based interceptive medicine.

Benjamin DayView profile

Senior Lecturer

• Foreign Policy Analysis
• Political Decision Making
• International Development
• +3 more

Benjamin Day is a Senior Lecturer in the Department of International Relations at the Coral Bell School of Asia Pacific Affairs, Australian National University (ANU). His research focuses on leaders' roles in foreign policy decision-making, particularly how leaders drive policy change. He co-authored *Foreign Policy Analysis: Classic and Contemporary Theory* (3rd ed., 2019), a leading textbook in the field. His recent work explores leaders' 'thinking practices' about global order, informed by elite interviews with over 100 politicians and policymakers. Education: BA (University of Queensland) BEcon (University of Queensland) MIS (University of Queensland) PhD (ANU, 2018) Research Interests: Political Decision Making and Foreign Aid Leaders and World Order Aid Policy Dynamics Elite Influence in Policymaking Academia-Policymaker Bridging Affiliations and Fellowships: Partners around the Globe Fellow, NATO Defence College (2025) Visiting Fellow, University of Edinburgh (2023) Australian National Fellow, King’s College London (2019) Centre Associate, ANU Development Policy Centre (since 2016) Contributions: Regularly publishes in platforms like *The Strategist*, *Devpolicy Blog*, and *The Conversation*. Designs courses for diplomats and public servants via the ANU Diplomacy Forum. Previously worked in international development for a decade, including health sector reform in Papua New Guinea. Labs/Teams: Active in the ANU’s Development Policy Centre and collaborates with institutions globally to advance policy-relevant research on foreign aid and leadership.

• Systems Biology
• Cancer Research
• Drug Resistance
• +7 more

Sampsa Hautaniemi is a Professor at the Department of Biochemistry and Developmental Biology within the Faculty of Medicine at the University of Helsinki. He serves as Principal Investigator of the Systems Biology of Drug Resistance in Cancer research group and holds docentship in the Faculty of Medicine. Professor Hautaniemi actively supervises doctoral students across multiple programs including the Doctoral Programme in Biomedicine, Doctoral Programme in Clinical Research, and Doctoral Programme in Integrative Life Science. His research focuses on systems biology approaches to understand drug resistance mechanisms in cancer, particularly ovarian cancer. His work integrates computational biology, genomics, epigenetics, and bioinformatics to develop precision medicine approaches for cancer treatment. His laboratory develops innovative computational methods and experimental models including patient-derived organoids to study tumor evolution, identify therapeutic targets, and predict treatment responses. Analysis of his recent publications reveals a strong emphasis on understanding tumor heterogeneity, clonal evolution during therapy, and the development of computational tools for cancer genomics. His work spans multiple disciplines including cancer biology, computational biology, immunology, and precision medicine, with a particular focus on high-grade serous ovarian cancer as a model system. Scientific Awards: The Anders Jahre Medical Prize to young medical scientists (2014) for outstanding research on systems biology and cancer The Finnish Medical Foundation 50-years jubileum award (2010) Professor Hautaniemi has supervised numerous doctoral students and early-career researchers, contributing significantly to cancer research education. His research is supported by multiple active projects including the DECIDER project (Clinical Decision via Integrating Multiple Data Levels to Overcome Chemotherapy Resistance in High-Grade Serous Ovarian Cancer) funded until 2026, as well as projects from the Academy of Finland, Cancer Foundation, and industry partners like Orion Corporation. His laboratory maintains a patient-derived organoid biobank for high-grade serous ovarian cancer and develops computational tools like Jellyfish for visualizing tumor evolution.

David HarrisonView profile

Professor

• Oncology
• Pharmacology
• Molecular Biology
• +3 more

Prof David Harrison is a Professor at the University of St Andrews' School of Medicine, affiliated with the Sir James Mackenzie Institute for Early Diagnosis and the Cellular Medicine Division. His research focuses on oncology, pharmacology, molecular biology, and AI-driven medical diagnostics. Key projects include the NuCana Biomed research agreement and the ICECAP initiative investigating immunopathology in severe COVID-19 cases. He supervises multiple PhD students and has contributed to advancements in drug development, cancer biology, and AI applications in pathology. His work spans clinical trials (e.g., RAMPART, NUC-3373 studies) and innovative imaging techniques (e.g., DESI-MSI for cancer metabolomics). Education: PhD (not explicitly stated in texts, inferred from academic rank). Research Interests: Prof Harrison’s expertise includes cancer drug mechanisms, molecular enzymology (e.g., 4-oxo-L-proline reductase), AI-driven pathology automation (e.g., cervical biopsy analysis), and immunological responses in critical illnesses. His lab develops tools for high-resolution histopathological imaging and explores metabolic-phenotypic links in tumors. Publications: Recent work includes studies on enzyme catalysis, clinical trial adaptations, and AI applications in diagnostics. These highlight his interdisciplinary approach to bridging basic science with translational medicine. Awards: None explicitly listed in the provided texts. Grants & Advising: Leads projects funded by NuCana Biomed (£171k) and Medical Research Scotland (£8k). Supervises eight PhD students focusing on drug mechanisms, imaging, and molecular biology. Labs/Teams: Collaborates within the Sir James Mackenzie Institute and cellular medicine teams, contributing to multidisciplinary research in early diagnosis and treatment strategies.

Silvia ArberView profile

Professor

• Molecular and cellular mechanisms of neuronal differentiation
• Neuronal circuit development and connectivity
• Motor system development and function
• +7 more

Silvia Arber holds a joint appointment as Full Professor for Neurobiology/Cell Biology at the Biozentrum, University of Basel, and serves as Senior Group Leader at the Friedrich Miescher Institute (FMI) in Basel, Switzerland. Her laboratory investigates the organization, function, and development of neuronal circuits controlling motor behavior, with a particular focus on how these circuits enable precise movement control. Arber obtained her PhD in 1996 from the Friedrich Miescher Institute under Pico Caroni, followed by postdoctoral training with Thomas Jessell at Columbia University (1996-2000), where she studied transcription factors in spinal cord neuronal differentiation. Her educational background includes Biology II studies at the Biozentrum of the University of Basel with graduation in Cell Biology (1987), a diploma thesis at the FMI (1990), and graduate work at the FMI (1992). Her research program centers on elucidating how neuronal circuits orchestrate accurate motor behavior in response to sensory cues and voluntary movement initiation. Using mouse as a model system, her laboratory employs multi-faceted approaches including advanced mouse genetics, viral technologies for transsynaptic circuit tracing, optogenetics and pharmacogenetics for functional manipulation, quantitative behavioral analysis, electrophysiology, and gene expression profiling. Her work has revealed precise synaptic interactions within dedicated motor circuit modules throughout the nervous system and how these impact function, with implications for understanding diseases causing motor deficits and spinal cord injury. Analysis of Arber's publication record shows a consistent focus on motor circuit organization, with particular emphasis on transcriptional control mechanisms, circuit connectivity mapping, and the relationship between developmental processes and functional circuit organization. Her work bridges molecular, cellular, and systems neuroscience, providing fundamental insights into how the nervous system controls movement. The Brain Prize (2022) Elected to the National Academy of Sciences of the United States (2020) Physiological Society Annual Review Prize Lecture (2019) Pradel Research Award (2018) W. Alden Spencer Award (2018) Louis-Jeantet Prize for Medicine (2017) ERC Advanced Grant (2010-2015) EMBO Member (2005) EMBO Young Investigator Award (2001) While specific students are not listed in the provided materials, Arber's laboratory has received significant research funding including an ERC Advanced Grant (2010-2015) and multiple prestigious awards supporting her research program. Her laboratory at the Biozentrum (Room 11.038) collaborates closely with the Friedrich Miescher Institute, where she serves as Senior Group Leader. The research group employs cutting-edge technologies for neural circuit analysis and has contributed fundamental insights into motor circuit organization, with implications for understanding and potentially treating movement disorders and spinal cord injuries.

Morteza GhorbaniView profile

Researcher

• Environmental Engineering
• Fluid Mechanics
• Nanotechnology
• +3 more

Dr. Morteza Ghorbani is a researcher and faculty member at Sabancı University's Faculty of Engineering and Natural Sciences (FENS), specializing in fluid mechanics and environmental engineering. He leads the AquaCav project, a collaborative effort with Oxford Brookes University, focused on developing sustainable water treatment solutions using hydrodynamic and acoustic cavitation. His research addresses global challenges such as PFAS pollution and wastewater management, with applications in biomedical devices and energy-efficient technologies. Key collaborations include projects funded by the International Science Partnership Fund (ISPF), leveraging his expertise in microfluidic systems and cavitation dynamics. Dr. Ghorbani's work combines experimental and numerical methods to optimize cavitation-based processes for environmental and biomedical applications. His contributions span from fundamental fluid dynamics studies to applied technologies like flexible cystoscopes and clot-on-a-chip platforms. Scientific achievements include the ISPF Research Collaboration Grant (2024) and advancements in PFAS removal, graphene exfoliation, and microalgae cultivation. His research group at Sabancı University explores interdisciplinary solutions at the intersection of engineering, nanotechnology, and sustainability.

Sarah JonesView profile

Associate Professor

• Thrombosis
• Haemostasis
• Platelet Biology
• +3 more

Dr. Sarah Jones is an Associate Professor in Thrombosis and Haemostasis at Manchester Metropolitan University, serving as Deputy Director of Research for the Department of Life Sciences. She leads the Thrombosis Group and holds an honorary Reader position at the University of Manchester. Academic Affiliation: Manchester Metropolitan University Secondary Appointment: University of Manchester (Honorary Reader) Over 20 years, Dr. Jones has pioneered research on platelet signaling pathways and their role in thrombosis. Her current work focuses on platelet-endothelial crosstalk in disease states, with emphasis on in vitro thrombosis modeling to replace animal testing. This research, funded by BBSRC, NC3Rs, and BHF, addresses cardiovascular disease mechanisms and translational antithrombotic testing. Her scientific publications demonstrate expertise in platelet biology (Pim kinase signaling, SIRT1 regulation, proteoglycan interactions) and thrombosis modeling. Recent work includes placental perfusion studies for pregnancy-related cardiovascular complications. Grants & Projects: UKRI (NC3Rs) Partnership and Impact Award (2025-2026) UKRI BBSRC/NC3Rs grant for human haemostasis models (2023-2025) British Heart Foundation collaborations (2021-2025) Dr. Jones supervises PhD students (Mishaal Reyman, Poppy White, etc.) and teaches on Biomedical Science, Cellular Science, and Clinical Haematology programs. She has developed innovative endothelialised in-vitro thrombosis models that reduce animal usage in cardiovascular research.

• Extreme Ultraviolet Optics
• Laser Physics
• Plasma Spectroscopy
• +3 more

Muharrem Bayraktar is an Assistant Professor at the MESA+ Institute for Nanotechnology at the University of Twente, specializing in XUV Optics. His research focuses on extreme ultraviolet (EUV) optics, plasma spectroscopy, and adaptive optical systems. He leads projects involving EUV source metrology, piezoelectric thin film actuators, and laser-driven plasma diagnostics. Research Interests: Bayraktar’s work centers on developing advanced EUV light sources for nanolithography applications. He investigates plasma physics in tin-based EUV emitters, optimizing thin film materials for adaptive optics, and improving spectral characterization techniques. His group explores piezoelectric thin films for precision wafer tables and multilayer mirror systems to enhance EUV beam control. Awards: 3rd Place in Simon Stevin Fellow Contest (2016) Best poster award (2018) Best poster award (2019) Advising & Activities: Supervises research on EUV source development and piezoelectric actuators. Engages in international collaborations on plasma diagnostics and adaptive optics. Active in presenting at conferences on topics like ‘EUV Source Metrology’ and ‘Nanolithography Systems’. Labs/Teams: Leads the XUV Optics team within MESA+, collaborating with industry partners on EUV lithography systems and advanced optical components.